 |
www.aurobindo.com |
|
|
Hyderabad,
15 April, 2002 |
|
|
SHARES
ALLOTTED TO TEMPLETON |
|
At
its Board Meeting held on Sunday the 14th April 2002, the Board of
Directors of Aurobindo Pharma Ltd. allotted one million equity shares
and equal number of share warrants to M/s. Templeton Strategic Emerging
Markets Fund LDC. The said investor has already brought in the requisite
funds.
Earlier, in the Board Meeting held on Friday the 12th April 2002, the
promoters were allotted 530,000 equity shares and an equal number of share warrants under a
preferential issue whose resolution was passed by the
members at the Extra-ordinary General Meeting (EGM) held on 15th January 2002. With this, the
promoters have subscribed to the full quota of one million equity shares and equal number of
share warrants as per the resolution that was approved at the EGM.
The allotment to Templeton Strategic Emerging Markets Fund LDC marks a
major milestone for Aurobindo Pharma. This will have a far-reaching effect
as far as the growth and progress of the company is concerned.
The restructuring of Aurobindo Pharma is fast nearing completion and this
landmark investment by a global major could well herald the beginning of a
series of impressive forays, including overseas listing for Aurobindo Pharma. |
|
|
|
|
|
PRESS
ROOM 
